SARS-CoV-2 Viral Diversity: Causes, Consequences, and Opportunities
The rapid spread of SARS-CoV-2 has been accompanied by the emergence of distinct viral clades, though their clinical significance remains unclear. In this webinar, Dr. Judd F. Hultquist discusses his recent data on how differences in virus genotype impact viral load and influence viral transmission and spread.
Topics:
Topics:
- Phylogenetic characteristics of SARS-CoV-2 infections in Chicago, Illinois and their relationship to clinical parameters.
- Differences in viral load, disease severity, and transmission between different clades of SARS-CoV-2.
Related Multimedia
-
Collaborating to Accelerate COVID-19 Research
Publish Date: May 15, 2020 -
Online Immunology Journal Club: Advances in Live-Attenuated Vaccine Development for Zika Virus
Publish Date: August 10, 2020 -
Exploring the Impact of SARS-CoV-2 Infection on the Central Nervous System
Publish Date: August 18, 2020
Explore Our Products
-
FRET-based peptide substrate for detection of protease activity of coronaviruses
-
CoV Protease Substrate-2 IF670
FRET-based peptide substrate for detection of protease activity of coronaviruses -
Anti-SARS-CoV Nucleoprotein Antibody, Clone 001 (Recombinant)
Rabbit monoclonal IgG antibody against SARS-CoV, SARS-CoV-2 (2019-nCoV) Nucleoprotein (HEK293-expressed recombinant) -
Human monoclonal IgG1 antibody against SARS-CoV-2 (2019-nCoV) S protein (HEK293-expressed recombinant)